Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Porsche May Kill the Electric Boxster Before It Ever Arrives - 2ChatGPT served as "suicide coach" in man's death, lawsuit alleges
- 3Vial marked 'Polonium 210' sparks scare during German Easter egg hunt
- 4CDC's upcoming vote on hepatitis B vaccine could impact childhood immunization
- 54 Coolers for Present day Kitchens
- 5 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- Ariana Grande and Jonathan Bailey will reunite for 'Sunday in the Park With George'
- Figure out How to Use the Experience of a Fender bender Legal counselor for Your Potential benefit
- Tech Patterns 2023: 12 Advancements to Keep an eye Out For
- Dominating the Mastercard Endorsement Cycle: Six Fundamental Stages
- 5 Superstar Couples That Motivate Relationship Objectives
- Indian rocket launches record-breaking BlueBird 6 smartphone satellite to orbit (video)
- 4 buzzy new TV shows to watch — plus the return of 'The Comeback,' 'Jury Duty' and more
- Civil rights leader Jesse Jackson hospitalized, family requests prayers
